In our study published in Molecular Cancer Therapeutics, we identified an intrinsic and adaptive feedback mechanism leading to resistance to Axl-targeting agents mediated by the upregulation of MerTK [68] when Axl was directly targeted. This evidence concerns the gene AXL and cancer.